A step into the future: Tether invests in neurotechnology
In a world where technology and innovation seem limitless, Tether, the operator of the popular stablecoin USDT, is taking a bold direction. On April 29, the company announced a strategic investment of $200 million in Blackrock Neurotech, affirming its majority position in this company specializing in neural implants. This investment, made through Tether Evo, a new division within Tether, underlines the company's commitment to merging human potential with technological advances.
Blackrock Neurotech, founded in 2008, is recognized worldwide as a pioneer in brain-computer interface (BCI) technology. The company has already enabled patients to control robotic arms, surf the web and even drive a car simply by thinking. This new injection of funds is aimed at commercializing and deploying medical solutions that have already proven their effectiveness with over 40 individuals, while continuing to innovate in research and development.
A promising collaboration for the future of medicine
Tether CEO Paolo Ardoino explains that the investment in Blackrock Neurotech is just the beginning of a series of initiatives by Tether Evo to push back the frontiers of technological innovation and human potential. “Blackrock Neurotech represents a leap towards a future where technology not only complements our human experience, but enhances it,” he said.
Florian Solzbacher, co-founder of Blackrock Neurotech, expressed his enthusiasm for the partnership, noting that Blackrock's mission to restore function in people with neurological disorders is a long-term commitment that requires dedicated and visionary partners like Tether.
This development comes shortly after Tether launched four new business divisions on April 18, diversifying its activities into data, finance, energy and education, demonstrating its ambition to play a key role at the intersection of technology and human evolution.
